AI-Powered Company Profile sungenomics.com

Sun Genomics Market Intelligence

5151 Shoreham Pl Ste 105, San Diego, California, 92122, United States Health Care, Hospital & Health Care Startup / Health Technology

Sun Genomics operates in Health Care, Hospital & Health Care, functioning as Startup and Health Technology, based in United States, founded in 2016.

19
Ingredients
17
Products
18
People Records
0
Certificates

AI Narrative Overview

Sun Genomics is active in Health Care, Hospital & Health Care, with 3 identified product associations including FLORÉ BABY | CUSTOM PROBIOTICS, FLORÉ GUT MICROBIOME TEST, and 3 ingredient links such as Bifidobacterium Longum - Probiotic, Bifidobacterium Lactis - Probiotic, operating from United States.

Ingredient Intelligence

Sun Genomics is linked to 3 ingredients: Bifidobacterium Longum - Probiotic, Bifidobacterium Lactis - Probiotic, Bifidobacterium Lactis - Whole. INCI names include Lactobacillus Ferment, Lactose. CAS references: 12650-88-3, 66087-12-1.

Product Intelligence

Sun Genomics has 3 product records: FLORÉ BABY | CUSTOM PROBIOTICS, FLORÉ GUT MICROBIOME TEST, FLORÉ BALANCE, under brands: SUNGENOMICS, within the Health Care ecosystem.

People Intelligence

Sun Genomics has 18 people records, including Customer Experience Manager, Research and Development Intern, across Manager, Intern, C suite levels.

Sun Genomics Connected Intelligence Graph

This profile combines organization, product, ingredient, and narrative signals into a higher-fidelity company record.

Ingredient SignalsView all 19

Bifidobacterium Longum - Probiotic

Lactobacillus Ferment

CAS: 12650-88-3 · INCI: Lactobacillus Ferment

Bifidobacterium Lactis - Probiotic

Lactose

CAS: 66087-12-1 · INCI: Lactose

Bifidobacterium Lactis - Whole

Lactose

CAS: 63-42-3 · INCI: Lactose

Product SignalsView all 17

FLORÉ BABY | CUSTOM PROBIOTICS

Brand: SUNGENOMICS · Industry: Health Care

FLORÉ GUT MICROBIOME TEST

Brand: SUNGENOMICS · Industry: Health Care

FLORÉ BALANCE

Brand: SUNGENOMICS · Industry: Health Care

Market and Ecosystem Signals

Decision Maker Context

Sun Genomics has 18 people records, including Customer Experience Manager, Research and Development Intern, across Manager, Intern, C suite levels.

MR

Megan Reynolds

Customer Experience Manager
Manager
meg******************
Access Contact
MP

Meera Prasad

Research and Development Intern
Intern
mee******************
Access Contact
NG

Neal Gidvani

Chief Operating Officer
C suite
cus****************************
Access Contact
Role Coverage Signals
View all 18 people

Explore the full intelligence profile for Sun Genomics

People, products, ingredients, and market context for Sun Genomics in Health Care, Hospital & Health Care.

Start for free

Company Intelligence Questions

Data-backed questions about Sun Genomics in Health Care, Hospital & Health Care, United States.

What products are associated with Sun Genomics?

Sun Genomics is linked to 3 product records: FLORÉ BABY | CUSTOM PROBIOTICS, FLORÉ GUT MICROBIOME TEST, FLORÉ BALANCE.

Which ingredients are linked to Sun Genomics?

Sun Genomics is associated with 3 ingredients: Bifidobacterium Longum - Probiotic, Bifidobacterium Lactis - Probiotic, Bifidobacterium Lactis - Whole. INCI names include: Lactobacillus Ferment, Lactose, Lactose.

Which industries does Sun Genomics operate in?

Sun Genomics operates in Health Care, Hospital & Health Care, with operations based in United States.

When did Sun Genomics start its operations?

Sun Genomics was founded in 2016, making it 10 years active, headquartered in United States.

Where is Sun Genomics headquartered?

Sun Genomics is headquartered at 5151 Shoreham Pl Ste 105, San Diego, California, 92122, United States, United States.

View Full Profile
Register for free to see full contact details, emails, 3 products, 3 ingredients and more for Sun Genomics.
Create Free Account
Already have an account? Sign in
Contact Sun Genomics

Fuel growth with unified, Trusted Data

  • No credit card required*

Pay only for what you use Plans start from $29

Global insights